Edwards Lifesciences Corp (NYSE: EW) is -10.66% lower on its value in year-to-date trading and has touched a low of $58.93 and a high of $96.12 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The EW stock was last observed hovering at around $66.50 in the last trading session, with the day’s gains setting it 1.62%.
Currently trading at $68.12, the stock is -1.25% and -16.35% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.48 million and changing 2.44% at the moment leaves the stock -16.03% off its SMA200. EW registered -14.70% loss for a year compared to 6-month gain of -20.83%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -21.98% loss in the last 1 month and extending the period to 3 months gives it a -24.45%, and is 7.63% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.37% over the week and 3.77% over the month.
Edwards Lifesciences Corp (EW) has around 19800 employees, a market worth around $41.04B and $6.00B in sales. Current P/E ratio is 28.04 and Fwd P/E is 23.86. Profit margin for the company is 24.55%. Distance from 52-week low is 15.59% and -29.13% from its 52-week high. The company has generated returns on investments over the last 12 months (18.17%).
Edwards Lifesciences Corp quarterly earnings per share for the current quarter are estimated at 0.68 with sales reaching $1.59B over the same period.The EPS is expected to grow by 8.26% this year, but quarterly earnings will post 5.90% year-over-year. Quarterly sales are estimated to grow 7.80% in year-over-year returns.
1871.0 institutions hold shares in Edwards Lifesciences Corp (EW), with institutional investors hold 86.76% of the company’s shares. The shares outstanding are 601.10M, and float is at 592.03M with Short Float at 1.03%. Institutions hold 85.98% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 52.96 million shares valued at $$5.06 billion. The investor’s holdings represent 8.8039 of the EW Shares outstanding. As of 2024-03-31, the second largest holder is BLACKROCK INC. with 52.42 million shares valued at $$5.01 billion to account for 8.7134 of the shares outstanding. The other top investors are STATE STREET CORP which holds 26.78 million shares representing 4.4508 and valued at over $$2.56 billion, while BANK OF NEW YORK MELLON CORP holds 3.1538 of the shares totaling 18.97 million with a market value of $$1.81 billion.
Edwards Lifesciences Corp (EW) Insider Activity
The most recent transaction is an insider sale by BOBO DONALD E JR, the company’s CVP,Strategy/Corp Development. SEC filings show that BOBO DONALD E JR sold 5,000 shares of the company’s common stock on Aug 14 ’24 at a price of $66.08 per share for a total of $0.33 million. Following the sale, the insider now owns 46936.0 shares.
Still, SEC filings show that on Jul 11 ’24, Lippis Daniel J. (CVP, JAPAC) disposed off 500 shares at an average price of $94.18 for $47090.0. The insider now directly holds 23,189 shares of Edwards Lifesciences Corp (EW).
